Skip directly to search Skip directly to A to Z list Skip directly to navigation Skip directly to page options Skip directly to site content


This image depicts Centers for Disease Control and Prevention (CDC), Microbiologist, Dr. Jane Basile, a staff member in the Fort Collins, Colorado, Division of Vector-Borne Diseases (DVBD), who was in the process of preparing reagents that would be used in the CDC-developed Zika IgM antibody-capture enzyme-linked immunosorbent assay (ELISA), referred to as the Zika MAC-ELISA test.
Additional Information:
“The Food and Drug Administration (FDA) has issued an Emergency Use Authorization for the CDC Zika IgM Antibody Capture Enzyme-Linked Immunosorbent Assay (Zika MAC-ELISA) for antibody testing. This assay has been introduced and is being used in qualified public health and Department of Defense laboratories in the United States. The Zika MAC-ELISA is used for the qualitative detection of Zika virus IgM antibodies in serum or cerebrospinal fluid collected from persons meeting the clinical and epidemiologic criteria for suspected Zika virus disease.”

Please note the link below, which leads to more information regarding the interpretation of Zika antibody test results.

High Resolution: Click here for hi-resolution image (25.96 MB)
Content Providers(s):CDC/ Sue Partridge, CDC- Ft. Collins
Creation Date:2016
Photo Credit:Sue Partridge, CDC- Ft. Collins
Links:CDC - Morbidity and Mortality Weekly Report (MMWR), “Interim Guidance for Interpretation of Zika Virus Antibody Test Results”, Weekly / June 3, 2016 / 65(21)
CDC - National Center for Emerging and Zoonotic Infectious Diseases (NCEZID); Division of Vector-Borne Diseases (DVBD); Zika virus
CDC Organization
Skip Navigation Links.

Skip Navigation Links.
Copyright Restrictions:None - This image is in the public domain and thus free of any copyright restrictions. As a matter of courtesy we request that the content provider be credited and notified in any public or private usage of this image.